Onconic Therapeutics Inc. (KOSDAQ:476060)
23,950
-1,150 (-4.58%)
At close: Mar 20, 2026
458.28% (1Y)
| Market Cap | 1.08T +547.0% |
| Revenue (ttm) | 53.39B +259.8% |
| Net Income | 15.78B |
| EPS | n/a |
| Shares Out | 44.89M |
| PE Ratio | 68.11 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 605,942 |
| Average Volume | 2,003,579 |
| Open | 25,000 |
| Previous Close | 25,100 |
| Day's Range | 23,850 - 25,100 |
| 52-Week Range | 3,878 - 28,900 |
| Beta | n/a |
| RSI | 56.30 |
| Earnings Date | Mar 20, 2026 |